Expert panel’s meet on COVID-19 vaccine approval begins
New Delhi: Key meeting of drug regulator's expert panel is currently underway to take a call on the emergency use ...
Read moreDetails
New Delhi: Key meeting of drug regulator's expert panel is currently underway to take a call on the emergency use ...
Read moreDetailsNew Delhi: Serum Institute of India (SII) has applied for emergency use authorization of the first Made in India Covid-19 ...
Read moreDetailsNew Delhi: The Serum Institute of India (SII) will seek emergency use authorisation for the AstraZeneca Covid 19 vaccine in ...
Read moreDetailsNew Delhi: Vaccine major Serum Institute of India Thursday said the COVID-19 vaccine developed by AstraZeneca and Oxford University is ...
Read moreDetailsNew Delhi: Adar Poonawalla, CEO and Owner of Serum Institute of India (SII) is putting $250 million of his family's ...
Read moreDetailsNew Delhi: The Drugs Controller General of India (DCGI) has given nod to Serum Institute of India (SII) for conducting ...
Read moreDetailsPune: "More than enough" doses of the COVID-19 vaccine developed by Oxford University and AstraZeneca will be reserved for the ...
Read moreDetails
When was the last time you read or saw something about India and the G20? And what do you recall...
Read moreDetails
The power corridors are abuzz again, but not over taxes or budgets this time. Eyeballs are fixed on who’ll get...
Read moreDetails
There is no doubt the way fighting in Gaza was ended and a peace process set in motion in the...
Read moreDetails
There is rejoicing as peace has started to return to the heart of the war-ravaged Middle East, and a ceasefire...
Read moreDetails
